Virtual Presentation

Choosing First-Line Therapy in Chronic Hepatitis B

Source: Choosing First-Line Therapy in Chronic Hepatitis B

Choosing First-Line Therapy in Chronic Hepatitis B


Faculty:

Emmet B. Keeffe, MD, MACP
  • Emmet B. Keeffe, MD, MACP

CME CREDIT INFORMATION

Release Date: 07/05/07

Expiration Date: 07/04/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Status: Please log in to view status


Begin the Virtual Presentation

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recount clinical data on available therapies for the treatment of chronic hepatitis B
  • Describe the key factors used in making decisions regarding first-line treatment in patients with chronic hepatitis B
  • Discuss the clinical situations in which each available HBV therapy would be the most appropriate choice for first-line treatment

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.